POLUZZI, ELISABETTA
POLUZZI, ELISABETTA
DIMEC - DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Docenti di ruolo di Ia fascia
Anticancer drugs and depression through the lens of disproportionality analysis: unveiling underlying confounders and tips for prescribers
2026 Raschi, E.; Nannini, M.; Montastruc, F.; Khouri, C.; Poluzzi, E.; De Ponti, F.
Characterizing post-mortem blood concentrations in methadone-related deaths
2026 Pelletti, Guido; Giunchi, Valentina; Fais, Paolo; Innocenti, Mattia; Giorgetti, Arianna; Poluzzi, Elisabetta; Fusaroli, Michele; Pelotti, Susi
Contemporary local anaesthetic-associated adverse events and mortality: searching for the root causes of the pharmacovigilance signal. Br J Anaesth 2026;136:411–13
2026 Raschi, E.; Tonetti, T.; Khouri, C.; Poluzzi, E.; De Ponti, F.
A narrative review on the environmental impact of medicines: from water analysis and in vivo studies to prescribing appropriateness, based on European and Italian legal frameworks
2025 Cristini, Irene; Poluzzi, Elisabetta; Soardo, Federica; Crisafulli, Salvatore; Polesello, Stefano; Kirchmayer, Ursula; Milani, Marco; Russo, Francesca; Nicoletti, Michele; Scroccaro, Giovanna; Deambrosis, Paola; Tavakolian Haghighi, Shima; Grisotto, Jacopo; Moretti, Ugo; Paolone, Giovanna; Trifirò, Gianluca
Assessing the environmental impact of medicines in Italy using data from the Italian Medicines Agency
2025 Giunchi, Valentina; Fusaroli, Michele; Cangini, Agnese; Fortinguerra, Filomena; Zito, Simona; Pierantozzi, Andrea; Lunghi, Carlotta; Poluzzi, Elisabetta; Trotta, Francesco
Attitudes, barriers, and facilitators toward tools supporting appropriate prescribing among healthcare professionals: a cross-sectional study
2025 Donati, M.; Giunchi, V.; Grillini, G.; Domenicali, M.; Lunardelli, M. L.; Pasini, V.; Milandri, S.; Mussoni, M.; Pieraccini, F.; Sangiorgi, E.; Raschi, E.; Colonnello, V.; Lunghi, C.; Poluzzi, E.
Chat GPT and the Challenges to Detect Potential Drug–Drug Interactions Related to QT Prolongation
2025 Raschi, E.; Poluzzi, E.; De Ponti, F.
Disproportionality analysis on semaglutide and nonarteritic anterior ischemic optic neuropathy in the FDA adverse event reporting system: An emerging pharmacovigilance signal?
2025 Procacci, Angela; Poluzzi, Elisabetta; De Ponti, Fabrizio; Raschi, Emanuel
From adoption to impact: linking prescribing tools to clinical outcomes—authors’ response
2025 Donati, Monia; Lunghi, Carlotta; Grillini, Giulia; Domenicali, Marco; Lunardelli, Maria Lia; Pasini, Veronica; Milandri, Susy; Mussoni, Monica; Pieraccini, Fabio; Sangiorgi, Elisa; Raschi, Emanuel; Colonnello, Valentina; Poluzzi, Elisabetta
Ivabradine, atrial fibrillation and stroke: a combined meta-analysis and FAERS disproportionality analysis
2025 Spadotto, A.; Fusaroli, M.; Carelli, M.; Nardi, E.; Amadori, M.; Massaro, G.; De Angelis, V.; Gatti, M.; Ciubine, V.; Raschi, E.; Poluzzi, E.; Diemberger, I.
Leveraging digital medication adherence technologies to enhance sustainability of European health systems: ENABLE's key recommendations
2025 van Boven, J. F. M.; Dima, A. L.; Wettermark, B.; Potočnjak, I.; Ágh, T.; Aarnio, E.; Achterbosch, M.; Aksoy, N.; Bago, M.; Barnestein-Fonseca, P.; Bitterman, N.; Burnier, M.; Burton, E.; Charitou, T.; Cordina, M.; Dilles, T.; Dovc, K.; Ekenberg, M.; Elseviers, M.; Fonseca, V. R.; de Geest, S.; Ghiciuc, C. M.; Goetzinger, C.; Gottlieb, H.; Granas, A. G.; Gregório, J.; Hafez, G.; Hansen, K.; Haupenthal, F.; Heerdink, R.; Herdeiro, M. T.; Hiligsmann, M.; Hosszú, D.; Jacome, C.; Kamberi, F.; Kamusheva, M.; Karageorgos, A.; Kardas, P.; Khanyk, N.; Lavalle, S.; Fernández, F. L.; Lunghi, C.; Menditto, E.; Mihajlovic, J.; Mucalo, I.; Mucherino, S.; Makovec, U. N.; Oleárová, A.; Hadžiabdić, M. O.; Petrou, C.; Petrovic, A. T.; Petrova, G.; Pinnock, H.; Poluzzi, E.; Qvarnström, M.; Rackow, P.; Ribaut, J.; Roque, F.; Sahm, L. J.; Schneider, M. P.; Smilkov, K.; Smits, D.; Tadic, I.; Trečiokienė, I.; Tsiligianni, I.; Vermeire, K.; Vervloet, M.; Vlček, J.; Vinker, S.; Volmer, D.; Vrijens, B.; Weinman, J.
Long-term surveillance of the anti-amyloid monoclonal antibody lecanemab: rights and duties of pharmacovigilance
2025 Donati, Monia; Boccia, Angela; De Ponti, Fabrizio; Poluzzi, Elisabetta; Raschi, Emanuel
The interface of depression and diabetes: treatment considerations
2025 Fanelli, G.; Raschi, E.; Hafez, G.; Matura, S.; Schiweck, C.; Poluzzi, E.; Lunghi, C.
Toward the harmonization of bioequivalence guidelines in Europe: Commentary on the state of the art and future priorities under ICH M13A for immediate‐release oral forms
2025 Nocera, Domenico; Forastiero, Giusi; Logreco, Andrea; Proietti, Alessia; Galluccio, Antonio; Lunghi, Carlotta; Poluzzi, Elisabetta; De Ponti, Fabrizio
Treatment sequences in moderate-to-severe psoriasis: a hospital-based retrospective analysis
2025 Boccia, A.; Giunchi, V.; Girau, L.; Lunghi, C.; La Placa, M.; Bardazzi, F.; Poluzzi, E.
Adopting STOPP/START Criteria Version 3 in Clinical Practice: A Q&A Guide for Healthcare Professionals
2024 Lunghi C.; Domenicali M.; Vertullo S.; Raschi E.; De Ponti F.; Onder G.; Poluzzi E.
Call to action: Pharmaceutical residues in the environment: threats to ecosystems and human health: Pharmaceutical Residues in the Environment: Threats to Ecosystems and Human Health
2024 Lunghi, C.; Valetto, M. R.; Caracciolo, A. B.; Bramke, I.; Caroli, S.; Bottoni, P.; Castiglioni, S.; Crisafulli, S.; Cuzzolin, L.; Deambrosis, P.; Giunchi, V.; Grisotto, J.; Marcomini, A.; Moretti, U.; Murgia, V.; Pandit, J.; Polesello, S.; Poluzzi, E.; Romizi, R.; Scarpa, N.; Scroccaro, G.; Sorrentino, R.; Sundström, A.; Wilkinson, J.; Paolone, G.
Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems
2024 Cutroneo, P. M.; Sartori, D.; Tuccori, M.; Crisafulli, S.; Battini, V.; Carnovale, C.; Rafaniello, C.; Capuano, A.; Poluzzi, E.; Moretti, U.; Raschi, E.
Enhancing Transparency in Defining Studied Drugs: The Open-Source Living DiAna Dictionary for Standardizing Drug Names in the FAERS
2024 Fusaroli M.; Giunchi V.; Battini V.; Puligheddu S.; Khouri C.; Carnovale C.; Raschi E.; Poluzzi E.
Environmental sustainability-an essential component of rational use of medicines
2024 Giunchi, V; Fusaroli, M; Linder, E; Villén, J; Raschi, E; Lunghi, C; Wettermark, B; Poluzzi, E; Nekoro, M
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Anticancer drugs and depression through the lens of disproportionality analysis: unveiling underlying confounders and tips for prescribers | Raschi, E.; Nannini, M.; Montastruc, F.; Khouri, C.; Poluzzi, E.; De Ponti, F. | 2026-01-01 | JOURNAL OF AFFECTIVE DISORDERS | - | 1.01 Articolo in rivista | - |
| Characterizing post-mortem blood concentrations in methadone-related deaths | Pelletti, Guido; Giunchi, Valentina; Fais, Paolo; Innocenti, Mattia; Giorgetti, Arianna; Poluzzi,... Elisabetta; Fusaroli, Michele; Pelotti, Susi | 2026-01-01 | INTERNATIONAL JOURNAL OF LEGAL MEDICINE | - | 1.01 Articolo in rivista | unpaywall-bitstream-1907382410.pdf; 414_2025_3620_MOESM1_ESM.docx |
| Contemporary local anaesthetic-associated adverse events and mortality: searching for the root causes of the pharmacovigilance signal. Br J Anaesth 2026;136:411–13 | Raschi, E.; Tonetti, T.; Khouri, C.; Poluzzi, E.; De Ponti, F. | 2026-01-01 | BRITISH JOURNAL OF ANAESTHESIA | - | 1.04 Replica / breve intervento (e simili) | - |
| A narrative review on the environmental impact of medicines: from water analysis and in vivo studies to prescribing appropriateness, based on European and Italian legal frameworks | Cristini, Irene; Poluzzi, Elisabetta; Soardo, Federica; Crisafulli, Salvatore; Polesello, Stefano...; Kirchmayer, Ursula; Milani, Marco; Russo, Francesca; Nicoletti, Michele; Scroccaro, Giovanna; Deambrosis, Paola; Tavakolian Haghighi, Shima; Grisotto, Jacopo; Moretti, Ugo; Paolone, Giovanna; Trifirò, Gianluca | 2025-01-01 | FRONTIERS IN DRUG SAFETY AND REGULATION | - | 1.01 Articolo in rivista | - |
| Assessing the environmental impact of medicines in Italy using data from the Italian Medicines Agency | Giunchi, Valentina; Fusaroli, Michele; Cangini, Agnese; Fortinguerra, Filomena; Zito, Simona; Pie...rantozzi, Andrea; Lunghi, Carlotta; Poluzzi, Elisabetta; Trotta, Francesco | 2025-01-01 | BJCP. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | - | 1.01 Articolo in rivista | Brit J Clinical Pharma - 2025 - Giunchi - Assessing the environmental impact of medicines in Italy using data from the.pdf |
| Attitudes, barriers, and facilitators toward tools supporting appropriate prescribing among healthcare professionals: a cross-sectional study | Donati, M.; Giunchi, V.; Grillini, G.; Domenicali, M.; Lunardelli, M. L.; Pasini, V.; Milandri, S....; Mussoni, M.; Pieraccini, F.; Sangiorgi, E.; Raschi, E.; Colonnello, V.; Lunghi, C.; Poluzzi, E. | 2025-01-01 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | - | 1.01 Articolo in rivista | Donati etal. EurJCliniPharm 2025.pdf; 228_2025_3852_MOESM1_ESM.docx |
| Chat GPT and the Challenges to Detect Potential Drug–Drug Interactions Related to QT Prolongation | Raschi, E.; Poluzzi, E.; De Ponti, F. | 2025-01-01 | CLINICAL PHARMACOLOGY & THERAPEUTICS | - | 1.04 Replica / breve intervento (e simili) | - |
| Disproportionality analysis on semaglutide and nonarteritic anterior ischemic optic neuropathy in the FDA adverse event reporting system: An emerging pharmacovigilance signal? | Procacci, Angela; Poluzzi, Elisabetta; De Ponti, Fabrizio; Raschi, Emanuel | 2025-01-01 | OBESITY RESEARCH & CLINICAL PRACTICE | - | 1.01 Articolo in rivista | - |
| From adoption to impact: linking prescribing tools to clinical outcomes—authors’ response | Donati, Monia; Lunghi, Carlotta; Grillini, Giulia; Domenicali, Marco; Lunardelli, Maria Lia; Pasi...ni, Veronica; Milandri, Susy; Mussoni, Monica; Pieraccini, Fabio; Sangiorgi, Elisa; Raschi, Emanuel; Colonnello, Valentina; Poluzzi, Elisabetta | 2025-01-01 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | - | 1.04 Replica / breve intervento (e simili) | - |
| Ivabradine, atrial fibrillation and stroke: a combined meta-analysis and FAERS disproportionality analysis | Spadotto, A.; Fusaroli, M.; Carelli, M.; Nardi, E.; Amadori, M.; Massaro, G.; De Angelis, V.; Gat...ti, M.; Ciubine, V.; Raschi, E.; Poluzzi, E.; Diemberger, I. | 2025-01-01 | FRONTIERS IN PHARMACOLOGY | - | 1.01 Articolo in rivista | fphar-16-1638923.pdf; Supplementary file 1.docx |
| Leveraging digital medication adherence technologies to enhance sustainability of European health systems: ENABLE's key recommendations | van Boven, J. F. M.; Dima, A. L.; Wettermark, B.; Potočnjak, I.; Ágh, T.; Aarnio, E.; Achterbosch..., M.; Aksoy, N.; Bago, M.; Barnestein-Fonseca, P.; Bitterman, N.; Burnier, M.; Burton, E.; Charitou, T.; Cordina, M.; Dilles, T.; Dovc, K.; Ekenberg, M.; Elseviers, M.; Fonseca, V. R.; de Geest, S.; Ghiciuc, C. M.; Goetzinger, C.; Gottlieb, H.; Granas, A. G.; Gregório, J.; Hafez, G.; Hansen, K.; Haupenthal, F.; Heerdink, R.; Herdeiro, M. T.; Hiligsmann, M.; Hosszú, D.; Jacome, C.; Kamberi, F.; Kamusheva, M.; Karageorgos, A.; Kardas, P.; Khanyk, N.; Lavalle, S.; Fernández, F. L.; Lunghi, C.; Menditto, E.; Mihajlovic, J.; Mucalo, I.; Mucherino, S.; Makovec, U. N.; Oleárová, A.; Hadžiabdić, M. O.; Petrou, C.; Petrovic, A. T.; Petrova, G.; Pinnock, H.; Poluzzi, E.; Qvarnström, M.; Rackow, P.; Ribaut, J.; Roque, F.; Sahm, L. J.; Schneider, M. P.; Smilkov, K.; Smits, D.; Tadic, I.; Trečiokienė, I.; Tsiligianni, I.; Vermeire, K.; Vervloet, M.; Vlček, J.; Vinker, S.; Volmer, D.; Vrijens, B.; Weinman, J. | 2025-01-01 | THE LANCET REGIONAL HEALTH. EUROPE | - | 1.03 Recensione in rivista | van Boven et al. The Lancet Regional Health - Europe 2025.pdf |
| Long-term surveillance of the anti-amyloid monoclonal antibody lecanemab: rights and duties of pharmacovigilance | Donati, Monia; Boccia, Angela; De Ponti, Fabrizio; Poluzzi, Elisabetta; Raschi, Emanuel | 2025-01-01 | ALZHEIMER'S RESEARCH & THERAPY | - | 1.01 Articolo in rivista | 13195_2025_Article_1699.pdf |
| The interface of depression and diabetes: treatment considerations | Fanelli, G.; Raschi, E.; Hafez, G.; Matura, S.; Schiweck, C.; Poluzzi, E.; Lunghi, C. | 2025-01-01 | TRANSLATIONAL PSYCHIATRY | - | 1.01 Articolo in rivista | Fanelli et al. Translational psychiatry 2025.pdf |
| Toward the harmonization of bioequivalence guidelines in Europe: Commentary on the state of the art and future priorities under ICH M13A for immediate‐release oral forms | Nocera, Domenico; Forastiero, Giusi; Logreco, Andrea; Proietti, Alessia; Galluccio, Antonio; Lung...hi, Carlotta; Poluzzi, Elisabetta; De Ponti, Fabrizio | 2025-01-01 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | - | 1.01 Articolo in rivista | BRJCLI~1.PDF |
| Treatment sequences in moderate-to-severe psoriasis: a hospital-based retrospective analysis | Boccia, A.; Giunchi, V.; Girau, L.; Lunghi, C.; La Placa, M.; Bardazzi, F.; Poluzzi, E. | 2025-01-01 | EXPERT OPINION ON BIOLOGICAL THERAPY | - | 1.01 Articolo in rivista | - |
| Adopting STOPP/START Criteria Version 3 in Clinical Practice: A Q&A Guide for Healthcare Professionals | Lunghi C.; Domenicali M.; Vertullo S.; Raschi E.; De Ponti F.; Onder G.; Poluzzi E. | 2024-01-01 | DRUG SAFETY | - | 1.01 Articolo in rivista | Lunghi et al. Drug Safety 2024.pdf; 40264_2024_1453_MOESM1_ESM.pdf |
| Call to action: Pharmaceutical residues in the environment: threats to ecosystems and human health: Pharmaceutical Residues in the Environment: Threats to Ecosystems and Human Health | Lunghi, C.; Valetto, M. R.; Caracciolo, A. B.; Bramke, I.; Caroli, S.; Bottoni, P.; Castiglioni, ...S.; Crisafulli, S.; Cuzzolin, L.; Deambrosis, P.; Giunchi, V.; Grisotto, J.; Marcomini, A.; Moretti, U.; Murgia, V.; Pandit, J.; Polesello, S.; Poluzzi, E.; Romizi, R.; Scarpa, N.; Scroccaro, G.; Sorrentino, R.; Sundström, A.; Wilkinson, J.; Paolone, G. | 2024-01-01 | DRUG SAFETY | - | 1.04 Replica / breve intervento (e simili) | - |
| Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems | Cutroneo, P. M.; Sartori, D.; Tuccori, M.; Crisafulli, S.; Battini, V.; Carnovale, C.; Rafaniello..., C.; Capuano, A.; Poluzzi, E.; Moretti, U.; Raschi, E. | 2024-01-01 | FRONTIERS IN DRUG SAFETY AND REGULATION | - | 1.01 Articolo in rivista | - |
| Enhancing Transparency in Defining Studied Drugs: The Open-Source Living DiAna Dictionary for Standardizing Drug Names in the FAERS | Fusaroli M.; Giunchi V.; Battini V.; Puligheddu S.; Khouri C.; Carnovale C.; Raschi E.; Poluzzi E. | 2024-01-01 | DRUG SAFETY | - | 1.01 Articolo in rivista | s40264-023-01391-4.pdf; 40264_2023_1391_MOESM1_ESM.docx |
| Environmental sustainability-an essential component of rational use of medicines | Giunchi, V; Fusaroli, M; Linder, E; Villén, J; Raschi, E; Lunghi, C; Wettermark, B; Poluzzi, E; N...ekoro, M | 2024-01-01 | INTERNATIONAL JOURNAL OF PHARMACY PRACTICE | - | 1.01 Articolo in rivista | - |